Cannara Biotech (STU:8CB0) Ending Cash Position : €3.39 Mil (As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Ending Cash Position?

Cannara Biotech's Ending Cash Position for the quarter that ended in Feb. 2025 was €3.39 Mil.

Cannara Biotech's quarterly Ending Cash Position increased from Aug. 2024 (€4.40 Mil) to Nov. 2024 (€6.92 Mil) but then declined from Nov. 2024 (€6.92 Mil) to Feb. 2025 (€3.39 Mil).

Cannara Biotech's annual Ending Cash Position declined from Aug. 2022 (€9.26 Mil) to Aug. 2023 (€2.91 Mil) but then increased from Aug. 2023 (€2.91 Mil) to Aug. 2024 (€4.40 Mil).

Cannara Biotech Ending Cash Position Historical Data

The historical data trend for Cannara Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Ending Cash Position Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Ending Cash Position

Get a 7-Day Free Trial

4.96

5.51

9.26

2.91

4.40

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Ending Cash Position	Get a 7-Day Free Trial															2.15	3.70	4.40	6.92	3.39

Cannara Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cannara Biotech's Ending Cash Position for the fiscal year that ended in Aug. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.836	+	1.561
	=	4.40

Cannara Biotech's Ending Cash Position for the quarter that ended in Feb. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.889	+	-3.495
	=	3.39

Cannara Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (STU:8CB0) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

LOVFF:USA LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Cannara Biotech Headlines

No Headlines